VIRAL ONCOGENES, INTERFERON, AND IMMUNITY
VIRAL ONCOGENES, INTERFERON, AND IMMUNITY
批准号:
3456029
负责人:
John Michael Routes
金额:
$9.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-07-01 至 1997-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Natural killer (NK) cells are an important component of cellular
antiviral immunity. Recent studies show that interferon (IFN)
promotes the selective lysis of Ad2/5 infected cells by activating
NK cells and protecting uninfected cells (IFN mediated
cytoprotection or IFN MCP) but not Ad infected cells from NK cell
mediated lysis. Expression of a single Ad gene, early region 1A
(EIA), blocks IFN MCP. This offers the first opportunity to study
the interference of IFN MCP by a single viral gene. Preliminary
genetic analysis reveals that expression of sequences in the first
exon of EIA is necessary for inhibition of IFN MCP. Expression of
SV40 LT, which shares homologous sequences with the first exon of
EIA, also inhibits IFN MCP. The homologous regions of EIA and SV40
LT have been recently shown to bind specific cellular proteins
(e.g., p105 retinoblastoma (Rb) gene product; p107; p60, cyclin A)
which has con-elated with some of the biological activities of these
viral oncoproteins. Based on these studies, it appears that the
inhibition of IFN MCP by SV40 LT and Ad EIA is mediated through the
same cellular pathway, likely by interacting with specific, common
cellular protein(s).
The first specific aim of this proposal: To map, by mutational
analysis, the genetic subregion(s) responsible for ElAs inhibition
of IFN MCP and to determine if the ability of mutant EIA proteins
to bind specific cellular proteins (p60 (cyclin A), p105 (Rb), pl07,
p300) correlates with ElA mediated inhibition of IFN MCP.
Human papillomavirus (HPV) early region 7 (E7), like SV40 LT, share
homologous sequences with the first exon of ElA . However,
preliminary studies show that HPV E7 expression in HeLa cells does
not block IFN MCP.
The second specific aim of this proposal: To determine if expression
of HPV16 or 18 E7 gene products in other types of human cells
inhibits IFN MCP. The following approaches will be used: a)
Comparison of IFN MCP in SV40 LT or HPV16 E7 expressing keratinocyte
and fibroblast cell lines. b) Determination of the significance of
IFN-induced, downregulation of E7 expression in HPV16/18 transformed
human cell lines in modulating the inhibition of IFN MCP. c)
Determination of the relationship between level of E7 expression and
IFN MCP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autoantibody production and regulatory T cells
-
批准号:8513699
-
项目类别:
-
资助金额:$37.83万
-
财政年份:2012
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:7845313
-
项目类别:
-
资助金额:$2.2万
-
财政年份:2009
-
负责人:John Michael Routes
-
依托单位:
Lymphoproliferative Disorders in Primary Immunodeficiencies
-
批准号:8206706
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:John Michael Routes
-
依托单位:
Lymphoproliferative Disorders in Primary Immunodeficiencies
-
批准号:8011454
-
项目类别:
-
资助金额:$28.29万
-
财政年份:2008
-
负责人:John Michael Routes
-
依托单位:
Lymphoproliferative Disorders in Primary Immunodeficiencies
-
批准号:7546580
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:John Michael Routes
-
依托单位:
Lymphoproliferative Disorders in Primary Immunodeficiencies
-
批准号:7371737
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:John Michael Routes
-
依托单位:
Lymphoproliferative Disorders in Primary Immunodeficiencies
-
批准号:7752861
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:7669150
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2007
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:8113471
-
项目类别:
-
资助金额:$27.92万
-
财政年份:2007
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:7901489
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2007
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:7316412
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2007
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:7484229
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2007
-
负责人:John Michael Routes
-
依托单位:
AMID in Apoptosis and p53-Mediated Downstream Effects
-
批准号:6922103
-
项目类别:
-
资助金额:$27.97万
-
财政年份:2004
-
负责人:John Michael Routes
-
依托单位:
DISSIMILAR IMMUNOGENICITIES OF ELA AND E7 ONCOPROTEINS
-
批准号:2693728
-
项目类别:
-
资助金额:$22.5万
-
财政年份:1998
-
负责人:John Michael Routes
-
依托单位:
DISSIMILAR IMMUNOGENICITIES OF ELA AND E7 ONCOPROTEINS
-
批准号:6376598
-
项目类别:
-
资助金额:$24.58万
-
财政年份:1998
-
负责人:John Michael Routes
-
依托单位:
DISSIMILAR IMMUNOGENICITIES OF ELA AND E7 ONCOPROTEINS
-
批准号:6172911
-
项目类别:
-
资助金额:$23.87万
-
财政年份:1998
-
负责人:John Michael Routes
-
依托单位:
DISSIMILAR IMMUNOGENICITIES OF ELA AND E7 ONCOPROTEINS
-
批准号:2896278
-
项目类别:
-
资助金额:$23.17万
-
财政年份:1998
-
负责人:John Michael Routes
-
依托单位:
DISSIMILAR IMMUNOGENICITIES OF ELA AND E7 ONCOPROTEINS
-
批准号:6513329
-
项目类别:
-
资助金额:$25.32万
-
财政年份:1998
-
负责人:John Michael Routes
-
依托单位:
EXAMINING HELICOBACTER PYLORI GASTRIC INFECTION IN PATIENTS WITH IMMUNODEFICENNCY
-
批准号:6245266
-
项目类别:
-
资助金额:$2.65万
-
财政年份:1997
-
负责人:John Michael Routes
-
依托单位:
VIRAL ONCOGENES, INTERFERON, AND IMMUNITY
-
批准号:2067045
-
项目类别:
-
资助金额:$9.79万
-
财政年份:1992
-
负责人:John Michael Routes
-
依托单位:
海外基金